or Try an Advanced Search...

    Technical Analysis for SGMT - Sagimet Biosciences Inc.

    Grade Last Price % Change Price Change
    C 5.33 3.50% 0.18
    SGMT closed up 3.5 percent on Friday, November 1, 2024, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical SGMT trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Support Bullish 3.50%
    NR7 Range Contraction 3.50%
    Wide Bands Range Expansion 3.50%
    Down 3 Days in a Row Weakness 3.50%
    MACD Bearish Signal Line Cross Bearish -0.19%
    Slingshot Bullish Bullish Swing Setup -0.19%
    Wide Bands Range Expansion -0.19%
    Older End-of-Day Signals for SGMT ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 19 hours ago
    Rose Above Previous Day's High about 23 hours ago
    Up 5% about 23 hours ago
    Up 3% about 23 hours ago
    Up 2% about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SGMT Chart by TradingView
    Basic chart:

    Profile

    Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne

    Is SGMT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
    Oct 18 Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat
    Oct 16 Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
    Oct 11 Sagimet gains on peer-reviewed data for lead asset in MASH
    Oct 11 Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
    Oct 1 Sagimet soars on FDA breakthrough therapy designation for its liver disease treatment
    Oct 1 Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH
    Oct 1 Sagimet Biosciences to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference and Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Sep 12 Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit
    Sep 4 Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
    See more SGMT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.71
    52 Week Low 2.13
    Average Volume 1,682,179
    200-Day Moving Average 4.86
    50-Day Moving Average 3.97
    20-Day Moving Average 5.16
    10-Day Moving Average 5.59
    Average True Range 0.52
    RSI (14) 58.33
    ADX 43.79
    +DI 29.80
    -DI 17.01
    Chandelier Exit (Long, 3 ATRs) 4.76
    Chandelier Exit (Short, 3 ATRs) 4.89
    Upper Bollinger Bands 6.41
    Lower Bollinger Band 3.91
    Percent B (%b) 0.57
    BandWidth 48.60
    MACD Line 0.48
    MACD Signal Line 0.55
    MACD Histogram -0.076
    Fundamentals Value
    Market Cap 161.9 Million
    Num Shares 30.4 Million
    EPS -1.18
    Price-to-Earnings (P/E) Ratio -4.52
    Price-to-Sales 99.52
    Price-to-Book 1.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.88
    Resistance 3 (R3) 5.89 5.71 5.79
    Resistance 2 (R2) 5.71 5.57 5.71 5.76
    Resistance 1 (R1) 5.52 5.49 5.62 5.51 5.73
    Pivot Point 5.35 5.35 5.39 5.34 5.35
    Support 1 (S1) 5.15 5.21 5.25 5.15 4.93
    Support 2 (S2) 4.98 5.12 4.97 4.90
    Support 3 (S3) 4.79 4.98 4.87
    Support 4 (S4) 4.78